Cargando…
A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy
BACKGROUND: Biliary atresia (BA) is a life-threatening liver disease of infancy, characterized by extrahepatic biliary obstruction, bile retention, and progressive liver injury. The Kasai portoenterostomy (KP) is BA's only nontransplant treatment. Its success is variable and depends on restorat...
Autores principales: | Tessier, Mary Elizabeth M., Shneider, Benjamin L., Brandt, Mary L., Cerminara, Dana N., Harpavat, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542754/ https://www.ncbi.nlm.nih.gov/pubmed/31193715 http://dx.doi.org/10.1016/j.conctc.2019.100370 |
Ejemplares similares
-
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy
por: Harpavat, Sanjiv, et al.
Publicado: (2023) -
Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy
por: Tyraskis, Athanasios, et al.
Publicado: (2015) -
The extended Kasai portoenterostomy for biliary atresia: A preliminary report
por: Ramachandran, Priya, et al.
Publicado: (2016) -
Long-Term Effects of Kasai Portoenterostomy for Biliary Atresia Treatment in Russia
por: Degtyareva, Anna, et al.
Publicado: (2020) -
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia
por: Nyholm, Iiris, et al.
Publicado: (2023)